• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

羟基脲通过上调 miR-7013-3p 调节 B16 黑色素瘤细胞的发育和存活。

Hydroxyurea regulates the development and survival of B16 Melanoma Cells by upregulating MiR-7013-3p.

机构信息

Department of Laboratory Animals, Jilin Provincial Key Laboratory of Animal Model, Jilin University, Changchun 130062, Jilin, P.R. China.

出版信息

Int J Med Sci. 2021 Mar 3;18(8):1877-1885. doi: 10.7150/ijms.52177. eCollection 2021.

DOI:10.7150/ijms.52177
PMID:33746605
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7976580/
Abstract

miRNAs are a family of short, noncoding RNAs that are involved in many processes in melanoma cells. MITF acts as a master regulator of melanocyte function, development and survival by modulating various genes. Hydroxyurea (HU) is used to treat melanoma, and miRNA expression is altered after HU treatment in B16 melanoma cells. In this study, we screened for miRNAs that were upregulated after HU treatment and that targeted the MITF gene. We found that miR-7013-3p exhibited increased expression after HU treatment and could bind to MITF. miR-7013-3p inhibited melanin production, proliferation, and migration and promoted apoptosis in B16 melanoma cells. The results may provide more information on the roles of miR-7013-3p in B16 melanoma cells.

摘要

miRNAs 是一类短的非编码 RNA,参与黑色素瘤细胞中的许多过程。MITF 通过调节各种基因,作为黑色素细胞功能、发育和存活的主调控因子发挥作用。羟基脲 (HU) 用于治疗黑色素瘤,HU 处理后 B16 黑色素瘤细胞中的 miRNA 表达发生改变。在本研究中,我们筛选了 HU 处理后上调并靶向 MITF 基因的 miRNAs。我们发现,HU 处理后 miR-7013-3p 表达增加,并能与 MITF 结合。miR-7013-3p 抑制 B16 黑色素瘤细胞中的黑色素生成、增殖和迁移,并促进细胞凋亡。这些结果可能为 miR-7013-3p 在 B16 黑色素瘤细胞中的作用提供更多信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/060a/7976580/e66e5d159e9e/ijmsv18p1877g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/060a/7976580/0a8a7be405ac/ijmsv18p1877g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/060a/7976580/d4bfa4454962/ijmsv18p1877g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/060a/7976580/12ef996ff281/ijmsv18p1877g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/060a/7976580/e725f5cb67f6/ijmsv18p1877g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/060a/7976580/19f6fb55b31f/ijmsv18p1877g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/060a/7976580/e66e5d159e9e/ijmsv18p1877g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/060a/7976580/0a8a7be405ac/ijmsv18p1877g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/060a/7976580/d4bfa4454962/ijmsv18p1877g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/060a/7976580/12ef996ff281/ijmsv18p1877g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/060a/7976580/e725f5cb67f6/ijmsv18p1877g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/060a/7976580/19f6fb55b31f/ijmsv18p1877g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/060a/7976580/e66e5d159e9e/ijmsv18p1877g006.jpg

相似文献

1
Hydroxyurea regulates the development and survival of B16 Melanoma Cells by upregulating MiR-7013-3p.羟基脲通过上调 miR-7013-3p 调节 B16 黑色素瘤细胞的发育和存活。
Int J Med Sci. 2021 Mar 3;18(8):1877-1885. doi: 10.7150/ijms.52177. eCollection 2021.
2
miRNA-183∼96∼182 regulates melanogenesis, cell proliferation and migration in B16 cells.miRNA-183∼96∼182 调控 B16 细胞中的黑色素生成、细胞增殖和迁移。
Acta Histochem. 2020 Apr;122(3):151508. doi: 10.1016/j.acthis.2020.151508. Epub 2020 Jan 21.
3
Contributes to the Progression of Melanoma Via Axis.通过 轴促进黑色素瘤进展。
Cancer Biother Radiopharm. 2020 Oct;35(8):596-604. doi: 10.1089/cbr.2019.3093. Epub 2020 Apr 30.
4
New target genes of MITF-induced microRNA-211 contribute to melanoma cell invasion.MITF 诱导的 microRNA-211 的新靶基因促进黑色素瘤细胞侵袭。
PLoS One. 2013 Sep 5;8(9):e73473. doi: 10.1371/journal.pone.0073473. eCollection 2013.
5
miR-380-3p regulates melanogenesis by targeting SOX6 in melanocytes from alpacas (Vicugna pacos).miR-380-3p 通过靶向羊驼(Vicugna pacos)黑素细胞中的 SOX6 来调节黑素生成。
BMC Genomics. 2019 Dec 10;20(1):962. doi: 10.1186/s12864-019-6343-4.
6
MicroRNA-141-3p and microRNA-200a-3p regulate α-melanocyte stimulating hormone-stimulated melanogenesis by directly targeting microphthalmia-associated transcription factor.miR-141-3p 和 miR-200a-3p 通过直接靶向小眼畸形相关转录因子调控α-促黑素细胞激素刺激的黑素生成。
Sci Rep. 2020 Feb 7;10(1):2149. doi: 10.1038/s41598-020-58911-w.
7
BRAF inhibition alters the microRNA cargo in the vesicular secretome of malignant melanoma cells.BRAF 抑制改变了恶性黑素瘤细胞囊泡分泌组中的 microRNA 载量。
Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):E5930-E5939. doi: 10.1073/pnas.1705206114. Epub 2017 Jul 6.
8
Licochalcone A restrains microphthalmia-associated transcription factor expression and growth by activating autophagy in melanoma cells via miR-142-3p/Rheb/mTOR pathway.甘草查尔酮 A 通过 miR-142-3p/Rheb/mTOR 通路激活自噬来抑制小眼畸形相关转录因子表达和黑色素瘤细胞生长。
Phytother Res. 2020 Feb;34(2):349-358. doi: 10.1002/ptr.6525. Epub 2019 Dec 2.
9
miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes.miR-137 通过下调多个致癌靶基因抑制黑素瘤细胞的侵袭。
J Invest Dermatol. 2013 Mar;133(3):768-775. doi: 10.1038/jid.2012.357. Epub 2012 Nov 15.
10
MicroRNA miR-21 regulates the metastatic behavior of B16 melanoma cells.微小 RNA miR-21 调节 B16 黑色素瘤细胞的转移行为。
J Biol Chem. 2011 Nov 11;286(45):39172-8. doi: 10.1074/jbc.M111.285098. Epub 2011 Sep 22.

引用本文的文献

1
MicroRNA as a Diagnostic Tool, Therapeutic Target and Potential Biomarker in Cutaneous Malignant Melanoma Detection-Narrative Review.微小 RNA 作为一种诊断工具、治疗靶点和潜在的生物标志物在皮肤恶性黑色素瘤检测中的应用-叙述性综述。
Int J Mol Sci. 2023 Mar 11;24(6):5386. doi: 10.3390/ijms24065386.
2
miR-330 targeting BCO2 is involved in carotenoid metabolism to regulate skin pigmentation in rainbow trout (Oncorhynchus mykiss).miR-330 靶向 BCO2 参与类胡萝卜素代谢,调节虹鳟(Oncorhynchus mykiss)皮肤色素沉着。
BMC Genomics. 2023 Mar 16;24(1):124. doi: 10.1186/s12864-023-09173-z.

本文引用的文献

1
Delineating the role of MITF isoforms in pigmentation and tissue homeostasis.阐明 MITF 异构体在色素沉着和组织稳态中的作用。
Pigment Cell Melanoma Res. 2020 Mar;33(2):279-292. doi: 10.1111/pcmr.12828. Epub 2019 Oct 16.
2
Growth Hormone Upregulates Melanocyte-Inducing Transcription Factor Expression and Activity via JAK2-STAT5 and SRC Signaling in GH Receptor-Positive Human Melanoma.生长激素通过JAK2-STAT5和SRC信号通路在生长激素受体阳性的人黑色素瘤中上调黑素细胞诱导转录因子的表达和活性。
Cancers (Basel). 2019 Sep 12;11(9):1352. doi: 10.3390/cancers11091352.
3
Nonmelanoma skin cancer associated with Hydroxyurea treatment: Overview of the literature and our own experience.
羟基脲治疗相关非黑素瘤皮肤癌:文献综述及我们的经验。
Dermatol Ther. 2019 Sep;32(5):e13043. doi: 10.1111/dth.13043. Epub 2019 Aug 16.
4
Ailanthone Induces Cell Cycle Arrest and Apoptosis in Melanoma B16 and A375 Cells.苦龙酮诱导黑素瘤 B16 和 A375 细胞周期停滞和凋亡。
Biomolecules. 2019 Jul 11;9(7):275. doi: 10.3390/biom9070275.
5
Hydroxyurea-Induced miRNA Expression in Sickle Cell Disease Patients in Africa.羟基脲对非洲镰状细胞病患者miRNA表达的影响
Front Genet. 2019 May 28;10:509. doi: 10.3389/fgene.2019.00509. eCollection 2019.
6
Cyclin-dependent kinase 5 regulates proliferation, migration, tyrosinase activity, and melanin production in B16-F10 melanoma cells via the essential regulator p-CREB.周期蛋白依赖性激酶 5 通过必要调节因子 p-CREB 调节 B16-F10 黑色素瘤细胞的增殖、迁移、酪氨酸酶活性和黑色素生成。
In Vitro Cell Dev Biol Anim. 2019 Jun;55(6):416-425. doi: 10.1007/s11626-019-00343-6. Epub 2019 May 8.
7
Hydroxyurea (hydroxycarbamide) for transfusion-dependent β-thalassaemia.羟基脲(羟基脲)用于输血依赖型β地中海贫血。
Cochrane Database Syst Rev. 2019 Mar 16;3(3):CD012064. doi: 10.1002/14651858.CD012064.pub2.
8
HGF/c-MET Signaling in Melanocytes and Melanoma.HGF/c-MET 信号在黑素细胞和黑色素瘤中的作用。
Int J Mol Sci. 2018 Dec 3;19(12):3844. doi: 10.3390/ijms19123844.
9
NPS - 2143 (hydrochloride) inhibits melanoma cancer cell proliferation and induces autophagy and apoptosis.NPS - 2143(盐酸盐)可抑制黑色素瘤癌细胞增殖,并诱导自噬和凋亡。
Med Sci (Paris). 2018 Oct;34 Focus issue F1:87-93. doi: 10.1051/medsci/201834f115. Epub 2018 Nov 7.
10
Subungual melanoma complicated by hydroxyurea-induced melanonychia with non-melanoma Hutchinson's sign.甲下黑色素瘤合并羟基脲诱发的黑甲伴非黑色素性哈钦森征。
Eur J Dermatol. 2018 Aug 1;28(4):559-561. doi: 10.1684/ejd.2018.3345.